Hot Life Science Investor Mandate 2: CVC Arm of Large Pharma Seeking Neuromodulation Devices

6 May

The strategic venture capital fund of large pharmaceutical company focuses on investments in companies developing pioneering bioelectronic medicines and technologies. The initial investments are typically ranging from $5-$7 million in Series A, and the fund will also consider follow-on investments. The fund is looking to invest in 5 to 7 companies over the next five years. The fund is looking for investment opportunities globally.

The fund is currently looking for new investment opportunities in the Biotech R&D and Medical Technology spaces. The fund focuses on two types of companies, those developing implantable devices targeting neuromodulation of the peripheral nervous system and those developing technologies that improve neuromodulation, such as miniaturized devices, enhanced batteries, etc. The firm is looking for companies generally in the pre-clinical stage of development although companies with in-human data are also open for review.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: